No Prescription |
 |
 | ||
|
Psorcutan Ointment Dovonex |
|
| ||
No Prescription » Prescription Drugs 13 » Psorcutan Ointment Dovonex Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:This medication is used to treat psoriasis. Calcipotriene is a form of vitamin D. It works by slowing down the growth of skin cells.How to use Calcipotriene TopUse this medication on the skin only. Apply a thin layer of the medication to the affected area and gently rub in usually once or twice daily for the ointment or twice daily for the cream or as directed by your doctor. Wash your hands after using unless you are using this medication to treat the hands. Do not apply the medication on the face in the eyes nose or mouth or inside the vagina. If you do get the medication in those areas flush with plenty of water.Do not apply more often or use longer than prescribed. This may increase the risk of side effects.Use this medication regularly to get the most benefit from it. To help you remember use it at the same time(s) each day.Inform your doctor if your condition does not improve or if it worsens. You should usually begin to see an improvement in your skin condition after 2 weeks of treatment.Calcipotriene Top is used to treat the following:Plaque Psoriasis Psoriasis of Scalp Buy Psorcutan Ointment Dovonex and other Prescription Drugs 13 products online at Medstore. 5001
About Psorcutan Ointment Dovonex: Product Type: Prescription Drugs 13 Psorcutan Ointment ( Dovonex Generic Calcipotriene ) Psorcutan Ointment (Dovonex Generic Calcipotriene) Dovonex Generic Calcipotriene 0 05 mg/g 30 gm tube Dovonex Generic Calcipotriene Psorcutan Ointment
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
